Category

Publications
September 14, 2023ByIn

Recommendations for the EU procedures for the authorisation and supervision of medicinal products for human use

2023-09-14-ECL-position-on-the-proposal-for-EU-Pharma-Regulation
Continue Reading
May 25, 2023ByIn

Factsheet: Let’s talk about weight and cancer

Continue Reading
March 15, 2023ByIn

ECL and EFPN recommendations for the revision of the EU legislation of medicines for rare diseases  

2023-0316_ECL-and-EFPN-Recommendations_Revision-of-the-EU-legislation-on-medicines-for-rare-diseases
Continue Reading
March 15, 2023ByIn

Infographic: Access to medicines for all patients with rare diseases  

2023-03-16-ECL-EFPN-infographic_revision-EU-legislation-on-medicines-for-rare-diseases
Continue Reading
March 15, 2023ByIn

ECL and Anticancer Fund recommendations for the revision of the EU general pharmaceutical legislation 

2023-03-16_ECL-and-Anticancer-Fund-recommendations_Revision-of-the-EU-general-pharmaceutical-legislation
Continue Reading
January 15, 2023ByIn

Report: The potential for academic development of medicines in Europe 

2023-03-23-Policy-paper_The-potential-for-academic-development-of-medicines-in-Europe
Continue Reading
January 15, 2023ByIn,

A better life for cancer patients and survivors: Reflections on comprehensive cancer rehabilitation

Continue Reading
December 2, 2022ByIn

Tobacco Control Scale 2021

TCS-Report-2021-Interactive-V4-1
Continue Reading
November 1, 2022ByIn

ECL gives feedback on EU reforms to tobacco tracking legislation

ECL-Response-to-Public-Consultation-on-Tobacco-Traceability-System-1
Continue Reading
September 1, 2022ByIn

WHO/Europe RC72 Ministerial Lunch: “Access tonovel, effective, high-cost medicines”

2022-WHO-Europe-RC72-OMI_ECL_contribution
Continue Reading
1 2 3 4 5 6 … 9